ORP

4.26%

4.5¢ orpheus uranium limited

We wondered where you went. It appears as though it was over to...

First 93 Last

Share
Profile

Follow
schlepti

74 Posts.

7

01/03/19

07:36

Post #: 37613796
Share

Originally posted by StarPlus: ↑

Significant miss-match between AIS and ARE modus of operandi. ARE is suffering the most out of it for lack of news from the Torrens drilling.

If things continues in the same fashion as they are travelling now it would be very hard for ARE share price to maintain and sustain the momentum.

Note, ARE built the momentum when drilling commencement was announced and lost after a month for lack of news.

ARE is an exploration company while AIS has both the attributes; mining production and exploration. Nonetheless, ARE has no choice but to go along with the way it is now. ARE is between the rock and hard place.

Nothing can be done!

Expand

We wondered where you went. It appears as though it was over to AIS.

ARE Price at posting: 2.2¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BUX

Buxton projects new graphite province discovery at WA Narryer play

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

There are more pages in this discussion • 41 more messages in this thread...

First 93 Last

Add ORP (ASX) to my watchlist

(20min delay)
Last 4.5¢		Change -0.002(4.26%)		Mkt cap ! $8.542M

Open	High	Low	Value	Volume
4.6¢	4.6¢	4.0¢	$13.40K	314.6K

Buyers (Bids)

No.	Vol.	Price($)
3	300622	4.0¢

Sellers (Offers)

Price($)	Vol.	No.
4.5¢	29378	1

View Market Depth

No.	Vol.	Price($)
2	270622	0.040
1	25000	0.038
1	27027	0.037
1	50000	0.036
1	6454	0.031

Price($)	Vol.	No.
0.045	29378	1
0.046	5000	1
0.048	10665	1
0.051	19999	1
0.053	5000	1

Last trade - 12.52pm 04/10/2024 (20 minute delay)

ORP (ASX) Chart

We wondered where you went. It appears as though it was over to...

BCI reaches close of funding facility for salt-first part of Mardie project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Buxton projects new graphite province discovery at WA Narryer play

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

We wondered where you went. It appears as though it was over to...

Top Stories

BCI reaches close of funding facility for salt-first part of Mardie project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Buxton projects new graphite province discovery at WA Narryer play

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News